0000899243-20-019029.txt : 20200713 0000899243-20-019029.hdr.sgml : 20200713 20200713214508 ACCESSION NUMBER: 0000899243-20-019029 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200709 FILED AS OF DATE: 20200713 DATE AS OF CHANGE: 20200713 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shawver Laura CENTRAL INDEX KEY: 0001551891 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39370 FILM NUMBER: 201026216 MAIL ADDRESS: STREET 1: 1255 CRESCENT GREEN DRIVE, SUITE 250 CITY: CARY STATE: NC ZIP: 27518 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nkarta, Inc. CENTRAL INDEX KEY: 0001787400 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474515206 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6000 SHORELINE COURT STREET 2: SUITE 102 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-215-0385 MAIL ADDRESS: STREET 1: 6000 SHORELINE COURT STREET 2: SUITE 102 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-07-09 0 0001787400 Nkarta, Inc. NKTX 0001551891 Shawver Laura C/O SILVERBACK THERAPEUTICS 500 FAIRVIEW AVE N #600 SEATTLE WA 98109 1 0 0 0 Stock Option (right to buy) 18.00 2020-07-09 4 A 0 10700 0.00 A 2030-07-08 Common Stock 10700 10700 D Stock Option (right to buy) 18.00 2020-07-09 4 A 0 18300 0.00 A 2030-07-08 Common Stock 18300 18300 D All shares subject to the option vest 100% on the first anniversary of July 9, 2020, or, if earlier, on the day immediately preceding the first annual meeting of the Issuer's stockholders in 2021 at which one or more members of the Issuer's board of directors are to be elected. Each grant, to the extent outstanding and otherwise unvested, will become fully vest should a "change in control" of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as described in the applicable award agreement). All shares subject to the option vest 100% on the first anniversary of July 1, 2020, or, if earlier, on the day immediately preceding the first annual meeting of the Issuer's stockholders in 2021 at which one or more members of the Issuer's board of directors are to be elected. Each grant, to the extent outstanding and otherwise unvested, will become fully vest should a "change in control" of the Issuer occur (as defined in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or "disability" (as defined in the applicable award agreement). /s/ Matthew Plunkett, Attorney-in-Fact for Laura Shawver 2020-07-10